Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;69(7):1157-1161.
doi: 10.1136/gutjnl-2019-320542. Epub 2020 Mar 16.

Challenges and opportunities for IBD drug development: from early stage to regulatory approval

Silvio Danese  1   2 , Elmer Schabel  3 , Mark Andrew Ainsworth  4   5 , Laurent Peyrin-Biroulet  6
Affiliations

Challenges and opportunities for IBD drug development: from early stage to regulatory approval

Silvio Danese et al. Gut. 2020 Jul.
No abstract available

Keywords: IBD; IBD clinical.

PubMed Disclaimer

Conflict of interest statement

Competing interests: SD has served as a speaker, consultant and advisory board member for Schering-Plough, Abbott (AbbVie) Laboratories, Merck and Co, UCB Pharma, Ferring, Cellerix, Millenium Takeda, Nycomed, Pharmacosmos, Actelion, α Wasserman, Genentech, Grunenthal, Pfizer, AstraZeneca, Novo Nordisk, Cosmo Pharmaceuticals, Vifor and Johnson and Johnson. LP-B has received consulting fees from Merck, AbbVie, Janssen, Genentech, Mitsubishi, Ferring, Norgine, Tillots, Vifor, Therakos, Pharmacosmos, Pilège, BMS, UCB Pharma, Hospira, Celltrion, Takeda, Biogaran, Boerhinger Ingelheim, Lilly, Pfizer, HAC-Pharma, Index Pharmaceuticals, Amgen and Sandoz; and lecture fees from Merck, AbbVie, Takeda, Janssen, Takeda, Ferring, Norgine, Tillots, Vifor, Therakos, Mitsubishi and HAC-Pharma.

MeSH terms

Substances

LinkOut - more resources